• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

通过基于 NGR 肽的药物传递系统靶向肿瘤血管。

Tumor vasculature targeting through NGR peptide-based drug delivery systems.

机构信息

Division of Molecular Oncology and IIT Network Research Unit of Molecular Neuroscience, San Raffaele Scientific Institute, via Olgettina 58, 20132 Milan, Italy.

出版信息

Curr Pharm Biotechnol. 2011 Aug;12(8):1128-34. doi: 10.2174/138920111796117373.

DOI:10.2174/138920111796117373
PMID:21470145
Abstract

Various peptide sequences have been discovered by selecting peptide-phage display libraries in vitro against specific receptors or in vivo in tumor-bearing animals. One class of these peptides is characterized by the presence of Asn-Gly-Asp (NGR), a structural motif that can recognize the endothelium and other cells of neoangiogenic vessels. Because of this property these peptides have been used by several investigators to deliver a variety of drugs, cytokines, nanoparticles, viruses and imaging agents to tumor blood vessels. Here we review the reports on these conjugates and discuss the structural, functional and stability properties of NGR embedded into different molecular scaffolds.

摘要

已经通过体外筛选针对特定受体的肽噬菌体展示文库或在荷瘤动物体内发现了各种肽序列。这些肽的一类特征在于存在 Asn-Gly-Asp (NGR),这是一种可以识别内皮细胞和新血管生成的其他细胞的结构基序。由于这种特性,这些肽已被许多研究人员用于将各种药物、细胞因子、纳米颗粒、病毒和成像剂递送至肿瘤血管。在这里,我们回顾了这些缀合物的报告,并讨论了嵌入不同分子支架中的 NGR 的结构、功能和稳定性特性。

相似文献

1
Tumor vasculature targeting through NGR peptide-based drug delivery systems.通过基于 NGR 肽的药物传递系统靶向肿瘤血管。
Curr Pharm Biotechnol. 2011 Aug;12(8):1128-34. doi: 10.2174/138920111796117373.
2
NGR-based strategies for targeting delivery of chemotherapeutics to tumor vasculature.基于 NGR 的策略,靶向递送达肿瘤血管的化疗药物。
Anticancer Agents Med Chem. 2012 Mar;12(3):239-46. doi: 10.2174/187152012800228751.
3
Vascular infarction by subcutaneous application of tissue factor targeted to tumor vessels with NGR-peptides: activity and toxicity profile.血管内因子通过 NGR 肽靶向肿瘤血管的皮下应用导致的血管梗塞:活性和毒性特征。
Int J Oncol. 2010 Dec;37(6):1389-97. doi: 10.3892/ijo_00000790.
4
Peptide-mediated targeting of cytokines to tumor vasculature: the NGR-hTNF example.多肽介导的细胞因子靶向肿瘤血管:NGR-hTNF 为例。
BioDrugs. 2013 Dec;27(6):591-603. doi: 10.1007/s40259-013-0048-z.
5
Research Progress of Radiolabeled Asn-Gly-Arg (NGR) Peptides for Imaging and Therapy.用于成像和治疗的放射性标记天冬酰胺-甘氨酸-精氨酸(NGR)肽的研究进展
Mol Imaging. 2020 Jan-Dec;19:1536012120934957. doi: 10.1177/1536012120934957.
6
Immunogenic and structural properties of the Asn-Gly-Arg (NGR) tumor neovasculature-homing motif.天冬酰胺-甘氨酸-精氨酸(NGR)肿瘤新生血管归巢基序的免疫原性和结构特性。
Mol Immunol. 2006 Apr;43(10):1509-18. doi: 10.1016/j.molimm.2005.10.009. Epub 2005 Dec 7.
7
In vivo NIRF imaging-guided delivery of a novel NGR-VEGI fusion protein for targeting tumor vasculature.用于靶向肿瘤血管的新型NGR-VEGI融合蛋白的体内近红外荧光成像引导递送
Amino Acids. 2014 Dec;46(12):2721-32. doi: 10.1007/s00726-014-1828-6. Epub 2014 Sep 3.
8
Infarction of tumor vessels by NGR-peptide-directed targeting of tissue factor: experimental results and first-in-man experience.通过NGR肽定向靶向组织因子实现肿瘤血管梗死:实验结果与首例人体试验经验
Blood. 2009 May 14;113(20):5019-27. doi: 10.1182/blood-2008-04-150318. Epub 2009 Jan 28.
9
The neovasculature homing motif NGR: more than meets the eye.新生血管归巢基序NGR:不止于所见。
Blood. 2008 Oct 1;112(7):2628-35. doi: 10.1182/blood-2008-04-150862. Epub 2008 Jun 23.
10
Mapping tumor vascular diversity by screening phage display libraries.通过筛选噬菌体展示文库来绘制肿瘤血管多样性图谱。
J Control Release. 2003 Aug 28;91(1-2):183-6. doi: 10.1016/s0168-3659(03)00236-0.

引用本文的文献

1
Integrin-Targeting Strategies for Adenovirus Gene Therapy.整合素靶向策略在腺病毒基因治疗中的应用。
Viruses. 2024 May 13;16(5):770. doi: 10.3390/v16050770.
2
A novel aminopeptidase N/CD13 inhibitor selectively targets an endothelial form of CD13 after coupling to proteins.一种新型的氨肽酶 N/CD13 抑制剂在与蛋白偶联后,可选择性地针对 CD13 的一种内皮形式。
Cell Mol Life Sci. 2024 Jan 30;81(1):68. doi: 10.1007/s00018-023-05102-1.
3
Cell-Penetrating and Targeted Peptides Delivery Systems as Potential Pharmaceutical Carriers for Enhanced Delivery across the Blood-Brain Barrier (BBB).
细胞穿透及靶向肽递送系统作为增强跨血脑屏障(BBB)递送的潜在药物载体
Pharmaceutics. 2023 Jul 21;15(7):1999. doi: 10.3390/pharmaceutics15071999.
4
Scandium-44: Diagnostic Feasibility in Tumor-Related Angiogenesis.钪-44:肿瘤相关血管生成中的诊断可行性。
Int J Mol Sci. 2023 Apr 17;24(8):7400. doi: 10.3390/ijms24087400.
5
Nucleic acid drug vectors for diagnosis and treatment of brain diseases.用于脑疾病诊断和治疗的核酸药物载体。
Signal Transduct Target Ther. 2023 Jan 17;8(1):39. doi: 10.1038/s41392-022-01298-z.
6
Synthesis of Ga-Labeled cNGR-Based Glycopeptides and In Vivo Evaluation by PET Imaging.镓标记的基于cNGR的糖肽的合成及正电子发射断层显像(PET)成像的体内评估。
Pharmaceutics. 2021 Dec 7;13(12):2103. doi: 10.3390/pharmaceutics13122103.
7
Research Progress of Radiolabeled Asn-Gly-Arg (NGR) Peptides for Imaging and Therapy.用于成像和治疗的放射性标记天冬酰胺-甘氨酸-精氨酸(NGR)肽的研究进展
Mol Imaging. 2020 Jan-Dec;19:1536012120934957. doi: 10.1177/1536012120934957.
8
In Vivo Tumor Growth Inhibition and Antiangiogenic Effect of Cyclic NGR Peptide-Daunorubicin Conjugates Developed for Targeted Drug Delivery.用于靶向药物递送的环 NGR 肽-柔红霉素缀合物的体内肿瘤生长抑制和抗血管生成作用。
Pathol Oncol Res. 2020 Jul;26(3):1879-1892. doi: 10.1007/s12253-019-00773-3. Epub 2019 Dec 9.
9
Phosphate-Catalyzed Succinimide Formation from an NGR-Containing Cyclic Peptide: A Novel Mechanism for Deammoniation of the Tetrahedral Intermediate.磷酸盐促进含 NGR 的环状肽形成琥珀酰亚胺:四面体中间体脱氨的新机制。
Molecules. 2018 Aug 31;23(9):2217. doi: 10.3390/molecules23092217.
10
Ga-Chelation and comparative evaluation of ,'-bis-[2-hydroxy-5-(carboxyethyl)benzyl]ethylenediamine-,'-diacetic acid (HBED-CC) conjugated NGR and RGD peptides as tumor targeted molecular imaging probes.镓螯合以及'-双-[2-羟基-5-(羧乙基)苄基]乙二胺-'-二乙酸(HBED-CC)偶联的NGR和RGD肽作为肿瘤靶向分子成像探针的比较评估。
Medchemcomm. 2017 Feb 16;8(3):673-679. doi: 10.1039/c7md00006e. eCollection 2017 Mar 1.